Company intelligence / Profile preview

Cercacor

Irvine, California, USA

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Cercacor is a health technology company dedicated to the development of non-invasive monitoring sensors and devices. Spun off from Masimo Corporation, the company leverages advanced Signal Extraction Technology (SET) to measure various blood constituents without the need for invasive blood draws. Its flagship consumer product, Ember, allows athletes to track hemoglobin levels and other physiological markers to optimize training and recovery. Cercacor continues to innovate in the field of non-invasive diagnostics, focusing on real-time health data for both consumer wellness and professional applications.

Therapeutic areas: HematologyOtherEndocrinologyPulmonology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Masimo

Beyond the preview

Go deeper on Cercacor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cercacor.

Explore the full profile